Tower Cancer Research Foundation supports forward thinking research work in Southern California and beyond. The goal of the Dr. Susan Love Fund award is to support young investigators to continue their laboratory studies while they improve their ability to get further funding. In general, the scientific advisory board evaluates grant applications based on the following criteria:
-
Novelty of hypothesis
-
Scientific quality
-
Potential for revealing something meaningful about breast cancer
-
Feasibility of the proposal
-
Evidence of institutional support for the project
Funding Terms
-
Dr. Susan Love Fund Career Development Grantees will be awarded a one-time payment of $100,000
-
All grant awards are for 1 year only. The grant award must be used to cover research related expenses between January 1, 2025 - December 31, 2025.
-
There are no opportunities of grant renewal.
-
Grant funds are to be applied towards salary, processing fees, equipment and/or supplies. There is no salary cap for Principal Investigators.
-
Grant funds are not permitted to be used for indirect expenses (i.e. rental expenses, equipment maintenance, and insurance fees are not allowable costs). Fringe benefits are not allowed. Please refer to the NIH grants policy for allowable direct costs.
Submission Procedures
-
Completed applications must be submitted electronically on our Grants Management System: ProposalCentral.
-
Submissions are due Monday, November 4, 2024 by 5pm (PST). Applicants will receive an email confirming receipt of the submission.
-
For questions regarding the application or application process contact Michelle Woodhill at (310) 299- 8470 or michelle@towercancer.org
-
Applications will be reviewed by a panel of renowned clinician-scientists determined by Tower Cancer Research Foundation. Applicants will be notified by no later than December 15, 2024, of the panel’s decision.
-
For technical questions about registering on our Grants Management System ProposalCentral (a division of Altum), please refer to ProposalCentral FAQ, the detailed ProposalCentral Guide, or for more support, email pcsupport@altum.com
-
A junior faculty position is not required.
-
Applicants must not be beyond the first five years of a junior faculty appointment.
-
Fellows and postdocs are allowed to apply.
-
Applicants must be located within the continental United States and Hawaii.
-
The project must entail research directed towards potential oncological clinical applications in the area of molecular therapeutics or diagnostics of cancer and/or the cause and prevention of breast cancer. The project may be laboratory-based or “translational”, meaning it may involve clinical subjects but must have a direct laboratory component.
-
The project MUST NOT use animal models. Dr. Susan Love did not support the use of animal models for research.
-
The Principal Investigator must hold either an MD or a PhD (or both) and working in an existing active lab.
-
50% of the Principal Investigator 's time must be protected time for research in general (not necessarily for the proposed project only)
-
Principal Investigators are not required to have funds already secured in order to apply for the Career Development Grant. Likewise, investigators with other private or government funding are still eligible to apply. Researchers who have received significant support within the last year need not apply (i.e., from a foundation, R01 grant, etc.)
Eligible Countries:
Sponsor Institute/Organizations: Tower Cancer Research Foundation
Sponsor Type:
Address: 8767 Wilshire Boulevard, Suite 401 Beverly Hills, CA 90211
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 04, 2024
Nov 04, 2024
$100,000
Affiliation: Tower Cancer Research Foundation
Address: 8767 Wilshire Boulevard, Suite 401 Beverly Hills, CA 90211
Website URL: https://www.towercancer.org/scientific-grant-application/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.